Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010–2013)

Journal of Clinical Immunology

Volumn 35, Issue 7, 2015, Pages 651-660

  Al Saud, Bandar ^a,b   Al Mousa, Hamoud ^a,b   Al Gazlan, Sulaiman ^a   Al Ghonaium, Abdulaziz ^a   Arnaout, Rand ^a,b   Al Seraihy, Amal ^a   Elshorbagi, Sahar ^a   Elsayed, Nazeema ^a   Afzal, Jawad ^a   Al Dhekri, Hasan ^a   Al Muhsen, Saleh ^a,c  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

epidemiology; infections; Primary immunodeficiencies disorders; severe combined immunodeficiency (SCID); stem cell transplantation

Indexed keywords

IMMUNOGLOBULIN;

ADENOSINE DEAMINASE DEFICIENCY; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANGIONEUROTIC EDEMA; ARTICLE; ATAXIA TELANGIECTASIA; AUTOINFLAMMATORY DISEASE; BARE LYMPHOCYTE SYNDROME; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHEDIAK HIGASHI SYNDROME; CHILD; CHRONIC DIARRHEA; CHRONIC GRANULOMATOUS DISEASE; COMBINED IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY; COMPLEMENT DEFICIENCY; CONGENITAL DISORDER; CONSANGUINITY; DIGEORGE SYNDROME; DYSKERATOSIS CONGENITA; FAILURE TO THRIVE; FAMILY HISTORY; FEMALE; GRISCELLI SYNDROME; GROUPS BY AGE; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPER IGE SYNDROME; HYPER IGM SYNDROME; IMMUNE DYSREGULATION; INFANT; INNATE IMMUNITY; LEUKOCYTE ADHESION DEFICIENCY; LOWER RESPIRATORY TRACT INFECTION; LUNG HEMORRHAGE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS CANDIDIASIS; MULTIPLE ORGAN FAILURE; NEWBORN; OMENN SYNDROME; ONSET AGE; PHAGOCYTE; PHENOTYPE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY; RECURRENT INFECTION; SAUDI ARABIA; SEPTIC SHOCK; SEVERE COMBINED IMMUNODEFICIENCY; SKIN INFECTION; STEM CELL TRANSPLANTATION; TERTIARY CARE CENTER; TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY; UPPER RESPIRATORY TRACT INFECTION; WISKOTT ALDRICH SYNDROME; B LYMPHOCYTE; COMPLICATION; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFECTION; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; T LYMPHOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFECTION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SAUDI ARABIA; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84946484244     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-015-0197-6     Document Type: Article

References (40)

1. Edgar J, Buckland M, Guzman D, Conlon N, Knerr V, Bangs C, et al. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years’ activity 2008–2012. Clin Exp Immunol. 2013;175:68–78.
2. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010; 135:264–72.
3. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517–24.
4. Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012;1250:62–72.
5. Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011;31:968–76.
6. Al Herz W. Primary immunodeficiency disorders in kuwait: first report from Kuwait national primary immunodeficiency registry (2004–2006). J Clin Immunol. 2008;28:186–93.
7. Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at Sultan Qaboos University Hospital. WAO J. 2012;5:52–6.
8. Reda S, Afifi H, Amine M. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29:343–51.
9. Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52.
10. Aghamohammadi A, Mohammadinejad P, Abolhassani H, Mirminachi B, Movahedi M, Gharagozlou M, et al. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J Clin Immunol. 2014;34(4):478–90.
11. Gathmann B, Goldacker S, Klima M, Belohradsky BHG, Notheis G, Ehl S. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80.
12. Naidoo R, Ungerer L, Cooper M, Pienaar S, Eley B. Primary immunodeficiencies: a 27-year review at a Tertiary Paediatric Hospital in Cape Town. South Afr J Clin Immunol. 2011;31:99–105.
13. Gathmann B, Binder N, Ehl S, Kindle G, ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167(3):479–91.
14. Javier F, Moore C, Sorensen R. Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann Allergy Asthma Immunol. 2000;84:25–30.
15. Al Attas R, Rahi A. Primary antibody deficiency in Arabs: first report from Eastern Saudi Arabia. J Clin Immunol. 1998;5(18):368–71.
16. Suliaman F, Al- Ghonaium A, Harfi H. High incidence of severe combined immune deficiency in the Eastern Province of Saudi Arabia. Paediatr Asthma, Allergy Immunol. 2006;19(1):14–8.
17. Al-Odaib AN, Abu-Amero KK, Ozand PT, Al-Hellani AM. A new era for preventive genetic programs in the Arabian Peninsula. Saudi Med J. 2003;24(11):1168–75.
18. Alsmadi O, Al-Ghonaium A, Al-Muhsen S, Arnaout R, Al-Dhekri H, Al-Saud B, et al. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia. BMC Med Genet. 2009;10:116.
19. Alsum Z, Hawwari A, Alsmadi O, Al-Hissi S, Borrero E, Abu-Staiteh A, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty five patients. J Clin Immunol. 2013;33(1):55–67.
20. Al-Saud B, Al-Sum Z, Alassiri H, Al-Ghonaium A, Al-Muhsen S, Al-Dhekri H, et al. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients. J Clin Immunol. 2013;33(8):1325–35.
21. Lipstein EA, Vorono S, Browning MF, Green NS, Kemper AR, Knapp AA, et al. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics. 2010;25:1226–35.
22. Al-Herz W, Al-Mousa H. Combined immunodeficiency: the Middle East experience. J Allergy Clin Immunol. 2013;131(3):658–60.
23. The Central Department of Statistics and Information (CDSI) website: www.cdsi.gov.sa. Accessed 15 Mar 2015.
24. Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M, et al. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood. 2011;118(19):5108–18.
25. Al-Mousa H, Al-Shammari Z, Al-Ghonaium A, Al-Dhekri H, Al-Muhsen S, Al-Saud B, et al. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. Biol Blood Marrow Transpl. 2010;16(6):818–23.
26. Buckley RH. Variable phenotypic expression of mutations in genes of the immune system. J Clin Invest. 2005;115:2974.
27. Woroniecka M, Ballow M. Office evaluation of children with recurrent infection. Paediatr Clin N Am. 2000;47(6):1211–24.
28. Buckley R. J Allergy Clin Immunol. 2004;113(4):793–800.
29. Seymour B, Miles J, Haeney M. Primary antibody deficiency and diagnostic delay. J Clin Pathol. 2005;58:546–7.
30. Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157 Suppl 1:3–11.
31. Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. 2013;33(2):317–24.
32. Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34(4):459–68.
33. Plotkin SA, Orenstein WA, Offit PA. Vaccines. 6th ed. Edinburgh: Elsevier/Saunders; 2013.
34. Alrabiaah AA, Alsubaie SS, Bukhari EI, Gad A, Alzamel FA. Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine. Ann Saudi Med. 2012;32(1):4–8.
35. Bernatowska E, Wolska-Kusnierz B, Pac M, Kurenko-Deptuch M, Zwolska Z, Casanova J, et al. Disseminated bacillus calmette-guérin infection and immunodeficiency. Emerg Infect Dis. 2007;13(5):799–801.
36. I˙kinciogˇulları A, Dogˇu F, iftci E, nal E, Ertem M, Reisli I, et at. An intensive approach to the treatment of disseminated BCG infection in a SCID patient. Bone Marrow Transplantation. 2002; 30, 45–47.
37. Paiman S, Siadati A, Mamishi S, Tabatabaie P, Khotaee G. Disseminated mycobacterium bovis infection after BCG vaccination. Iran J Allergy Asthma Immunol. 2006;5(3):133–7.
38. Marciano B, Huang C, Joshi G, Rezaei N, Carvalho B, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133:1134–41.
39. Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2005;115(2):391–8.
40. Chan K, Davis J, Pai SY, Bonilla FA, Puck JM, Apkon M. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab. 2011;104:383–9.